Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor: a Phase I Study
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Methionine enkephalin (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 13 Jul 2010 Planned end date changed from 1 Jul 2008 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 02 Aug 2008 New trial record.